Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD98hc VNARs for crossing the blood brain barrier and type IV VNAR libraries

Anti-CD98hc VNARs for crossing the blood brain barrier and type IV VNAR libraries

US Patent 12258414 · Granted Mar 25, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

TFR-specific binding moieties and transcytosis method to select VNARs that cross2025
TFR-specific binding moieties and transcytosis method to select VNARs that cross2025
TFR-specific binding moieties and transcytosis method to select VNARs that cross2025
Transferrin receptor (TFR)-selective binding peptides capable of crossing the bl2025
Transferrin receptor (TFR)-selective binding peptides capable of crossing the bl2025
Transferrin receptor (TFR)-selective binding peptides capable of crossing the bl2025
Transferrin receptor (TFR)-selective binding peptides capable of crossing the bl2025
Type-II VNAR polypeptides which bind human TfR-1, encoding nucleic acids thereof2025
Type-II VNAR polypeptides which bind human TfR-1, encoding nucleic acids thereof2025
Type-II VNAR polypeptides which bind human TfR-1, encoding nucleic acids thereof2025
Type-II VNAR polypeptides which bind human TfR-1, encoding nucleic acids thereof2025
TfR selective binding compounds and related methods2024